지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술대회자료
- 저자정보
- 발행연도
- 2001.1
- 수록면
- 103 - 112 (10page)
이용수
초록· 키워드
오류제보하기
Bone homeostasis is maintained by a balance between activities of osteoblasts(bone forming cells) and osteoclasts (bone resorbing cells). The activities of these cells are closely regulated by multiple factors including hormones and cytokines. The cessation of estrogen at menopause disrupts the balanced regulation and is the main cause of osteoporosis in postmenopausal women. Recent molecular biological studies led to a discovery of tumor necrosis factor(TNF) and TNF receptor families genes that play critical roles in the regulation of osteoclast formation and function. RANKL (receptor activator of nuclear factor kappa B ligand; also called ODF, TRANCE, and OPGL) expressed on cells supporting osteoclast is essential for osteoclast differentiation, activation, and survival. RANK, the counter-receptor for RANKL, is expressed on progenitor and mature osteoclasts. The interaction between RANKL and RANK is requlated by a soluble decoy receptor OPG (osteoprotegerin). Gene knock out studies of these molecules showed profound effects on bone. These results prompted development of new strategies for treatment of bone diseases. Inhibition of osteoclast activity by blocking the RANKL-RANK interaction using OPG is being attempted. Research on the signaling pathways of RANK is also actively carried out. Screening natural products that inhibit the RANKL-RANK interaction or the activity of obteoclasts would be another effective means to a new drug target for bone resorbing diseases.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
RANK Signaling Pathways and Key Molecules Inducing Osteoclast Differentiation
대한의생명과학회지
2017 .12
-
Gene Profiling in Osteoclast Precursors by RANKL Using Microarray
대한의생명과학회지
2013 .06
-
cAMP-response Element-binding Protein Is not Essential for Osteoclastogenesis Induced by Receptor Activator of NF-κB Ligand
International Journal of Oral Biology
2005 .01
-
대추 물 추출물이 RANKL에 의해 유도되는 파골세포 분화에 미치는 영향
동의생리병리학회지
2014 .01
-
대추 물 추출물이 RANKL에 의해 유도되는 파골세포 분화에 미치는 영향
동의생리병리학회지
2014 .02
-
Attenuation of RANKL-induced Osteoclast Formation via p38-mediated NFATc1 Signaling Pathways by Extract of Euphorbia Lathyris L
대한골대사학회지
2016 .01
-
녹제초 추출물이 파골세포 분화 및 골 흡수에 미치는 영향
한방재활의학과학회지
2019 .01
-
소청룡탕이 파골세포 분화억제와 골흡수에 미치는 영향
대한한의학회지
2017 .09
-
Extracts of Flavoparmelia sp. Inhibit Receptor Activator of Nuclear Factor-κB Ligand-Mediated Osteoclast Differentiation
대한골대사학회지
2019 .01
-
Can denosumab be a substitute, competitor, or complement to bisphosphonates?
The Korean Journal of Pain
2017 .01
-
α-Tocopheryl Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption
대한골대사학회지
2012 .01
-
두충의 물 추출물이 파골세포의 분화에 미치는 영향
동의생리병리학회지
2009 .01
-
Anti-Osteoclast Therapy in Bone Disease
대한약학회 학술대회
2005 .01
-
파골세포의 분화에 커규민의 억제 작용기전
동의생리병리학회지
2008 .01
-
파골세포에 대한 커큐민의 효과
동의생리병리학회지
2008 .01
-
Control of Osteoclasts as a Therapeutic Approach to Osteoporosis and Other Bone Diseases
대한약학회 학술대회
2005 .01
-
P2Y<sub>6</sub> 수용체 길항제의 파골세포 분화 촉진 효과 규명
약학회지
2015 .01
-
Effect of Cornus Officinalis on Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL)-induced Osteoclast Differentiation
대한골대사학회지
2012 .01
-
Negative regulators in RANKL-induced osteoclastogenesis
International Journal of Oral Biology
2007 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0